Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2026 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2026 Earnings Call Transcript May 14, 2026Sangamo Therapeutics, Inc. misses on earnings expectations.
Posts Tagged ‘NASDAQ:SGMO’
Sangamo Therapeutics (SGMO) Shares Stabilize Amid Recent Key Pipeline Update
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is one of the stocks under $1 that will explode.
10 Stocks Under $1 That Will Explode
In this piece, we discuss the 10 Stocks Under $1 That Will Explode. U.S.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2025 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2025 Earnings Call Transcript November 6, 2025Sangamo Therapeutics, Inc. misses on earnings expectations.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2025 Earnings Call Transcript
Sangamo Therapeutics, Inc.
Sangamo Therapeutics Announces Positive Phase 1/2 STAAR Study Results for Fabry Gene Therapy
Sangamo Therapeutics Inc. (NASDAQ:SGMO) is one of the best penny stocks under $1 to buy now.
H.C. Wainwright Reaffirms Buy Rating on Sangamo After Promising Gene Therapy Data
Sangamo Therapeutics Inc. (NASDAQ:SGMO) ranks among the best CRISPR stocks to buy. Following the release of Sangamo Therapeutics Inc.
Top 10 CRISPR Stocks to Buy Now
In this article, we will take a look at the Top 10 CRISPR Stocks to Buy Now.
H.C. Wainwright Maintains Buy Rating on Sangamo Therapeutics (SGMO)
With an unchanged $10 price target, H.C. Wainwright maintained its Buy rating on Sangamo Therapeutics, Inc. (NASDAQ:SGMO) on May 29. Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2025 Earnings Call Transcript
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2024 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2024 Earnings Call Transcript March 17, 2025Sangamo Therapeutics, Inc. misses on earnings expectations.
15 Small-Cap Stocks Poised to Outperform in 2025
Fifteen small-cap stocks—predominantly under the technology sector—are taking center stage this year, boasting triple- to quadruple-digit performance in their share prices...
Top 11 CRISPR Stocks to Invest In
In this article, we will take a look at the Top 11 CRISPR Stocks to Invest in.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2024 Earnings Call Transcript
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2024 Earnings Call Transcript
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript May 9, 2024 Sangamo Therapeutics, Inc.
5 Hot Penny Stock On the Move
This article presents an overview of the 5 Hot Penny Stock On the Move. For a detailed overview of such stocks, read our article, 15 Hot Penny Stock On the Move. 5.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q3 2023 Earnings Call Transcript November 2, 2023 Operator: Good morning, and thank you for standing by.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2023 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q2 2023 Earnings Call Transcript August 8, 2023 Sangamo Therapeutics, Inc. misses on earnings expectations.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2023 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2023 Earnings Call Transcript April 27, 2023 Operator: Good day and thank you for standing by.
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2022 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2022 Earnings Call Transcript February 22, 2023 Operator: Good day, ladies and gentlemen, and thank you, for standing by.
10 Best Gene Editing Stocks To Buy
In this article, we discuss 10 best gene editing stocks to buy. A report by The Wall Street Journal dated September 16 suggests that Intellia Therapeutics, Inc.
Wasatch Global on Sangamo (SGMO): “We Remain Optimistic About its Future Prospects”
Wasatch Global Investors, an investment management firm, published its “Wasatch Ultra Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded...
Is Sangamo Therapeutics (SGMO) Stock a Buy For 2021?
Wasatch Ultra Growth Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here.
Hedge Funds Are Dumping Sangamo Therapeutics, Inc. (SGMO)
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Is Sangamo Therapeutics, Inc. (SGMO) Going to Burn These Hedge Funds?
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock...
Here’s What Hedge Funds Think About Sangamo Therapeutics, Inc. (SGMO)
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Here’s What Hedge Funds Think About Sangamo Therapeutics, Inc. (SGMO)
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
Here’s Why Investors Are Watching Sangamo Biosciences, GNC Holdings, and Three Other Stocks Today
Markets are mixed on Wednesday as investors get ready to digest a flurry of earnings, and await Federal Reserve’s summary of commentary of the current economic condition, also...
Earnings Wrap: Transocean (RIG), XPO Logistics (XPO), Exelixis (EXEL), 2 More
All three index futures are pointing north in pre-market trading as the Bank of England just announced that it would cut interest rates for the first time in seven years, to 0...
One Tech Stock Made Investors Happy Today & One Healthcare Company You Should Follow Hedge Funds Into
One of the stocks that stands out on Thursday is Envivio Inc (NASDAQ:ENVI).
Wayne Holman, Ridgeback Capital Like Sangamo Biosciences
Wayne Holman, Ridgeback Capital: Wayne Holman's hedge fund Ridgeback Capital Management recently disclosed the purchasing of some 3.6 million shares of Sangamo Biosciences, Inc...
Biotech-Focused Hedge Fund is Bullish on ChemoCentryx Inc (CCXI)
Tracking the activity of hedge funds via their filings with the Securities and Exchange Commission is particularly crucial, since these filings reveal the latest moves made by...
Hedge Fund Resource Center
